Pivot Files Three New Provisional Patents for the Delivery of Cannabinoids
February 01, 2018 04:00 ET
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”), is pleased to announce that it has filed three...
Pivot Enters Into Standstill Agreement
December 27, 2017 04:00 ET
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Dec. 27, 2017 (GLOBE NEWSWIRE) -- via NetworkNewsWire -- Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”) wishes to announce that it has...
Pivot Pharmaceuticals To Commence Trading on CSE
December 18, 2017 05:00 ET
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (OTCQB:PVOTF) (“Pivot” or the “Company”), an emerging biopharmaceutical company, is pleased to announce that...